Literature DB >> 33546667

Nutritional status and quality of life in interstitial lung disease: a prospective cohort study.

Alisar A Kanjrawi1, Lara Mathers2, Susanne Webster3, Tamera J Corte3,4,5, Sharon Carey1,6.   

Abstract

BACKGROUND: Malnutrition and altered body composition are well-documented in chronic pulmonary diseases; however, investigation of nutritional status in interstitial lung disease (ILD) is limited. This study aimed to describe the nutritional status of ILD patients within three diagnostic groups and explore the relationship between nutritional status and quality of life (QoL).
METHODS: Consecutive patients attending an ILD clinic within a tertiary referral hospital in Sydney, Australia were studied. Weight, body-mass-index, anthropometrics, handgrip strength (HGS), subjective global assessment and QoL questionnaires (EQ-5D-5L and King's-Brief Interstitial-Lung-Disease 'K-BILD') were collected. Associations between nutritional status and QoL were analysed.
RESULTS: Ninety participants were recruited and categorised: (1) Idiopathic Pulmonary Fibrosis (IPF) (2) Connective-Tissue Disease associated-ILD (CTD-ILD) or (3) Other (non-IPF/non-CTD ILD). Median age was 66.5 (18) years. Four-percent of patients were underweight and 50% were overweight or obese. Median HGS was 71%-(25.3) of predicted and was correlated to all measures of QoL including EQ-5D health-state index (r = 0.376, p < 0.0001), patient-reported EQ-5D-5L Visual Analogue Score (r = 0.367, p < 0.0001) and K-BILD total score (r = 0.346, p = 0.001). Twenty-three percent of the variance in K-BILD total score (F = 12.888, p < 0.0001) was explained by HGS (ß = 0.273, p = 0.006) and forced vital capacity % predicted (ß = 0.331, p = 0.001).
CONCLUSIONS: Although a small number of ILD patients were malnourished, a large proportion of the cohort were overweight or obese. Handgrip strength was compromised and correlated to QoL. Future research with a larger cohort is required to explore the role of HGS as a predictor of QoL.

Entities:  

Keywords:  Lung disease; Nutritional status; Quality of life

Mesh:

Year:  2021        PMID: 33546667      PMCID: PMC7863253          DOI: 10.1186/s12890-021-01418-5

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  44 in total

1.  Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis.

Authors:  Baruch Vainshelboim; Jose Oliveira; Liora Yehoshua; Israela Weiss; Benjamin Daniel Fox; Oren Fruchter; Mordechai Reuven Kramer
Journal:  Respiration       Date:  2014-10-23       Impact factor: 3.580

2.  Prevalence and consequences of nutritional depletion in lung transplant candidates.

Authors:  C Schwebel; I Pin; D Barnoud; G Devouassoux; P Y Brichon; P Chaffanjon; O Chavanon; C Sessa; D Blin; M Guignier; X Leverve; C Pison
Journal:  Eur Respir J       Date:  2000-12       Impact factor: 16.671

3.  Risk factors of acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Y Kondoh; H Taniguchi; T Katsuta; K Kataoka; T Kimura; O Nishiyama; K Sakamoto; T Johkoh; M Nishimura; K Ono; M Kitaichi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2010-07       Impact factor: 0.670

4.  The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire.

Authors:  Amit S Patel; Richard J Siegert; Katherine Brignall; Patrick Gordon; Sophia Steer; Sujal R Desai; Toby M Maher; Elisabetta A Renzoni; Athol U Wells; Irene J Higginson; Surinder S Birring
Journal:  Thorax       Date:  2012-05-03       Impact factor: 9.139

5.  Muscular weakness assessment: use of normal isometric strength data. The National Isometric Muscle Strength (NIMS) Database Consortium.

Authors: 
Journal:  Arch Phys Med Rehabil       Date:  1996-12       Impact factor: 3.966

6.  Impact of body weight on long-term survival after lung transplantation.

Authors:  William F Kanasky; Stephen D Anton; James R Rodrigue; Michael G Perri; Thomas Szwed; Maher A Baz
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

7.  Weight loss as a predictor of mortality in patients with interstitial lung disease.

Authors:  Janelle Pugashetti; Julia Graham; Noelle Boctor; Cesar Mendez; Elena Foster; Maya Juarez; Richart Harper; Brian Morrissey; Michael Kadoch; Justin M Oldham
Journal:  Eur Respir J       Date:  2018-09-16       Impact factor: 16.671

8.  Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001-2013.

Authors:  Barry S Shea; Praveen Akuthota; Dominic C Marshall; Justin D Salciccioli
Journal:  Eur Respir J       Date:  2018-01-18       Impact factor: 16.671

9.  The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends in England from 1998 to 2010.

Authors:  Vidya Navaratnam; Andrew W Fogarty; Rachel Glendening; Tricia McKeever; Richard B Hubbard
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

10.  Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study.

Authors:  Sabina A Guler; Seo Am Hur; Scott A Lear; Pat G Camp; Christopher J Ryerson
Journal:  Respir Res       Date:  2019-03-12
View more
  5 in total

1.  Provision of pulmonary rehabilitation in Latin America 18 months after the COVID-19 pandemic: A survey of the Latin American Thoracic Association.

Authors:  Vicente Benavides-Cordoba; Marisol Barros-Poblete; Rodolfo P Vieira; Guillermo Mazzucco; Guilherme Fregonezi; Rodrigo Torres-Castro
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

2.  Health-Related Quality of Life in Spanish Schoolchildren and Its Association with the Fitness Status and Adherence to the Mediterranean Diet.

Authors:  Rosario Pastor; Cristina Bouzas; Irene Albertos; Carolina García; Ángela García; Teresa Prieto; Jorge Velázquez; Elena Sánchez-Jiménez; Rocío Rodríguez; Francisco Javier Martín; Angélica María Campón; Josep A Tur
Journal:  Nutrients       Date:  2022-05-31       Impact factor: 6.706

3.  Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study.

Authors:  Paola Faverio; Alessia Fumagalli; Sara Conti; Fabiana Madotto; Francesco Bini; Sergio Harari; Michele Mondoni; Tiberio Oggionni; Emanuela Barisione; Paolo Ceruti; Maria Chiara Papetti; Bruno Dino Bodini; Antonella Caminati; Angela Valentino; Stefano Centanni; Donatella Noè; Matteo Della Zoppa; Silvia Crotti; Marco Grosso; Samir Giuseppe Sukkar; Denise Modina; Marco Andreoli; Roberta Nicali; Giulia Suigo; Federica De Giacomi; Sara Busnelli; Elena Cattaneo; Lorenzo Giovanni Mantovani; Giancarlo Cesana; Alberto Pesci; Fabrizio Luppi
Journal:  ERJ Open Res       Date:  2022-03-07

Review 4.  Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice.

Authors:  Dinesh Khanna; Alain Lescoat; David Roofeh; Elana J Bernstein; Ella A Kazerooni; Michael D Roth; Fernando Martinez; Kevin R Flaherty; Christopher P Denton
Journal:  Arthritis Rheumatol       Date:  2021-11-10       Impact factor: 15.483

5.  Management of patients with fibrosing interstitial lung diseases.

Authors:  Lee E Morrow; Daniel Hilleman; Mark A Malesker
Journal:  Am J Health Syst Pharm       Date:  2022-01-24       Impact factor: 2.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.